Frontiers in Aging Neuroscience Aging Neuroscience Review Article
暂无分享,去创建一个
[1] M. Vreugdenhil,et al. Calcium and normal brain ageing. , 2010, Cell calcium.
[2] D. Surmeier,et al. Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease. , 2010, Cell calcium.
[3] B. A. Reyes,et al. Dopaminergic neurotoxicity of HIV-1 gp120: Reactive oxygen species as signaling intermediates , 2010, Brain Research.
[4] Z. Qin,et al. Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases , 2009, Acta Pharmacologica Sinica.
[5] M. Michaelis,et al. Genomic and biochemical approaches in the discovery of mechanisms for selective neuronal vulnerability to oxidative stress , 2009, BMC Neuroscience.
[6] D. Praticò. Oxidative stress hypothesis in Alzheimer's disease: a reappraisal. , 2008, Trends in pharmacological sciences.
[7] S. Przedborski,et al. Oxidative Stress in Parkinson's Disease , 2008, Annals of the New York Academy of Sciences.
[8] Xudong Huang,et al. Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42. , 2008, Journal of neurochemistry.
[9] J. Stamler,et al. Redox-based regulation of signal transduction: principles, pitfalls, and promises. , 2008, Free radical biology & medicine.
[10] Winnie S. Liang,et al. Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons , 2008, Proceedings of the National Academy of Sciences.
[11] E. Klann,et al. Superoxide-induced potentiation in the hippocampus requires activation of ryanodine receptor type 3 and ERK. , 2008, Journal of neurophysiology.
[12] J. Zimmermann,et al. Reversible disulfide bond formation of intracellular proteins probed by NMR spectroscopy. , 2007, Free radical biology & medicine.
[13] P. Reddy,et al. Mitochondrial dysfunction in aging and Alzheimer's disease: strategies to protect neurons. , 2007, Antioxidants & redox signaling.
[14] D. Surmeier,et al. Calcium, ageing, and neuronal vulnerability in Parkinson's disease , 2007, The Lancet Neurology.
[15] Xue-wen Chen,et al. Genome-wide transcriptome profiling of region-specific vulnerability to oxidative stress in the hippocampus. , 2007, Genomics.
[16] T. Foster,et al. Calcium homeostasis and modulation of synaptic plasticity in the aged brain , 2007, Aging cell.
[17] E. Klann,et al. Calcium release by ryanodine receptors mediates hydrogen peroxide-induced activation of ERK and CREB phosphorylation in N2a cells and hippocampal neurons. , 2007, Cell calcium.
[18] N. Schuff,et al. Measurement of hippocampal subfields and age-related changes with high resolution MRI at 4T , 2007, Neurobiology of Aging.
[19] R. Giffard,et al. Selective Dysfunction of Hippocampal CA1 Astrocytes Contributes to Delayed Neuronal Damage after Transient Forebrain Ischemia , 2007, The Journal of Neuroscience.
[20] M. Aschner,et al. Role of glutathione in determining the differential sensitivity between the cortical and cerebellar regions towards mercury-induced oxidative stress. , 2007, Toxicology.
[21] Dwight C. German,et al. Mitochondria mass is low in mouse substantia nigra dopamine neurons: Implications for Parkinson's disease , 2007, Experimental Neurology.
[22] L. Moran,et al. The medial and lateral substantia nigra in Parkinson’s disease: mRNA profiles associated with higher brain tissue vulnerability , 2007, Neurogenetics.
[23] M. Starkey,et al. Gene expression profiles of metabolic enzyme transcripts in Alzheimer's disease , 2007, Brain Research.
[24] J. Langston,et al. Decreased susceptibility to oxidative stress underlies the resistance of specific dopaminergic cell populations to paraquat-induced degeneration , 2006, Neuroscience.
[25] M. Cuénod,et al. Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: Relevance to schizophrenia , 2006, Neuroscience.
[26] M. Segal,et al. Control of neuronal plasticity by reactive oxygen species. , 2006, Antioxidants & redox signaling.
[27] E. Klann,et al. Sources and targets of reactive oxygen species in synaptic plasticity and memory. , 2006, Antioxidants & redox signaling.
[28] J. Sanchez-Ramos,et al. Neuroanatomical mapping of DNA repair and antioxidative responses in mouse brain: Effects of a single dose of MPTP. , 2006, Neurotoxicology.
[29] J. Lincoln,et al. Selective susceptibility of different populations of sympathetic neurons to diabetic neuropathy in vivo is reflected by increased vulnerability to oxidative stress in vitro , 2006, Neuroscience Letters.
[30] S. Ballinger,et al. Free radicals, mitochondria, and oxidized lipids: the emerging role in signal transduction in vascular cells. , 2006, Circulation research.
[31] W. Markesbery,et al. DNA oxidation in Alzheimer's disease. , 2006, Antioxidants & redox signaling.
[32] B. Kaina,et al. DNA damage-induced cell death by apoptosis. , 2006, Trends in molecular medicine.
[33] Shaharyar M. Khan,et al. Oxidative stress, mitochondrial dysfunction, and stress signaling in Alzheimer's disease. , 2006, Current Alzheimer research.
[34] C. Hidalgo. Cross talk between Ca2+ and redox signalling cascades in muscle and neurons through the combined activation of ryanodine receptors/Ca2+ release channels , 2005, Philosophical Transactions of the Royal Society B: Biological Sciences.
[35] Maria Speranza Desole,et al. Hormones Are Key Actors in Gene X Environment Interactions Programming the Vulnerability to Parkinson's Disease: Glia as a Common Final Pathway , 2005, Annals of the New York Academy of Sciences.
[36] Xue-wen Chen,et al. High intrinsic oxidative stress may underlie selective vulnerability of the hippocampal CA1 region. , 2005, Brain research. Molecular brain research.
[37] Ling Lin,et al. Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection. , 2005, Human molecular genetics.
[38] J. Andersen,et al. Role of oxidative stress in paraquat‐induced dopaminergic cell degeneration , 2005, Journal of neurochemistry.
[39] Andrei Rozov,et al. Presynaptic Ca2+ dynamics, Ca2+ buffers and synaptic efficacy. , 2005, Cell calcium.
[40] Robert S. Balaban,et al. Mitochondria, Oxidants, and Aging , 2005, Cell.
[41] J. Cano,et al. Inflammatory process as a determinant factor for the degeneration of substantia nigra dopaminergic neurons , 2004, Journal of Neural Transmission.
[42] Xiongwei Zhu,et al. Mitochondrial failures in Alzheimer's disease , 2004, American journal of Alzheimer's disease and other dementias.
[43] Eric Klann,et al. Reactive oxygen species and synaptic plasticity in the aging hippocampus , 2004, Ageing Research Reviews.
[44] C. B. Pickett,et al. The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress. , 2004, Free radical biology & medicine.
[45] I. Kohane,et al. Gene regulation and DNA damage in the ageing human brain , 2004, Nature.
[46] M. Segal,et al. Hydrogen peroxide as a diffusible signal molecule in synaptic plasticity , 2004, Molecular Neurobiology.
[47] George Perry,et al. Oxidative stress signalling in Alzheimer's disease , 2004, Brain Research.
[48] Charles DeCarli,et al. Regional NAD(P)H:quinone oxidoreductase activity in Alzheimer’s disease , 2004, Neurobiology of Aging.
[49] D. Ferrari,et al. Calcium and apoptosis: facts and hypotheses , 2003, Oncogene.
[50] Bente Pakkenberg,et al. Aging of the human cerebellum: A stereological study , 2003, The Journal of comparative neurology.
[51] M. Segal,et al. Paradoxical Actions of Hydrogen Peroxide on Long-Term Potentiation in Transgenic Superoxide Dismutase-1 Mice , 2003, The Journal of Neuroscience.
[52] T. Wieloch,et al. Flow cytometric analysis of mitochondria from CA1 and CA3 regions of rat hippocampus reveals differences in permeability transition pore activation , 2003, Journal of neurochemistry.
[53] W. Dauer,et al. Parkinson's Disease Mechanisms and Models , 2003, Neuron.
[54] G. Rotilio,et al. Neurodegeneration in amyotrophic lateral sclerosis: the role of oxidative stress and altered homeostasis of metals , 2003, Brain Research Bulletin.
[55] T. Wieloch,et al. Brain damage in a mouse model of global cerebral ischemia Effect of NMDA receptor blockade , 2003, Brain Research.
[56] G. Tomasevic,et al. Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma , 2003, Nature Medicine.
[57] C. Barnstable,et al. Mitochondrial uncoupling protein 2 in the central nervous system: neuromodulator and neuroprotector. , 2003, Biochemical pharmacology.
[58] T. Wieloch,et al. Mitochondrial oxidative stress after global brain ischemia in rats , 2002, Neuroscience Letters.
[59] E. Klann,et al. Hippocampal memory and plasticity in superoxide dismutase mutant mice , 2002, Physiology & Behavior.
[60] W. Streit. Microglia as neuroprotective, immunocompetent cells of the CNS , 2002, Glia.
[61] K. Hensley,et al. Oxidative stress in brain aging Implications for therapeutics of neurodegenerative diseases , 2002, Neurobiology of Aging.
[62] A. Godzik,et al. Cysteine regulation of protein function – as exemplified by NMDA-receptor modulation , 2002, Trends in Neurosciences.
[63] F. Cardozo-Pelaez,et al. Effects of diethylmaleate on DNA damage and repair in the mouse brain. , 2002, Free radical biology & medicine.
[64] J. Langston,et al. Environmental Risk Factors and Parkinson's Disease: Selective Degeneration of Nigral Dopaminergic Neurons Caused by the Herbicide Paraquat , 2002, Neurobiology of Disease.
[65] E. Klann,et al. Potentiation of Hippocampal Synaptic Transmission by Superoxide Requires the Oxidative Activation of Protein Kinase C , 2002, The Journal of Neuroscience.
[66] K. Davies,et al. Calcium and oxidative stress: from cell signaling to cell death. , 2002, Molecular immunology.
[67] Hui Zhang,et al. Co-culture with astrocytes or microglia protects metabolically impaired neurons , 2001, Mechanisms of Ageing and Development.
[68] F. Aloisi. Immune function of microglia , 2001, Glia.
[69] D. Sanchís,et al. Uncoupling protein 2 in the brain: distribution and function. , 2001, Biochemical Society transactions.
[70] Jeffrey D. Rothstein,et al. From charcot to lou gehrig: deciphering selective motor neuron death in als , 2001, Nature Reviews Neuroscience.
[71] M. Smith,et al. Chemistry and biochemistry of oxidative stress in neurodegenerative disease. , 2001, Current medicinal chemistry.
[72] J. Obeso,et al. Dopamine Cell Degeneration Induced by Intraventricular Administration of 6-Hydroxydopamine in the Rat: Similarities with Cell Loss in Parkinson's Disease , 2001, Experimental Neurology.
[73] W. Burke,et al. Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria. , 2001, Free radical biology & medicine.
[74] T. Bates,et al. Activation of murine microglial cell lines by lipopolysaccharide and interferon‐γ causes NO‐mediated decreases in mitochondrial and cellular function , 2001, The European journal of neuroscience.
[75] M. Mishina,et al. Real‐time, two‐dimensional visualization of ischaemia‐induced glutamate release from hippocampal slices , 2001, The European journal of neuroscience.
[76] Todd B. Sherer,et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.
[77] G. Barrionuevo,et al. Impairment of Long-term Potentiation and Associative Memory in Mice That Overexpress Extracellular Superoxide Dismutase , 2000, The Journal of Neuroscience.
[78] K. Davies,et al. Mitochondrial free radical generation, oxidative stress, and aging. , 2000, Free radical biology & medicine.
[79] Rafael Yuste,et al. From form to function: calcium compartmentalization in dendritic spines , 2000, Nature Neuroscience.
[80] Masahiko Watanabe,et al. Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain , 2000, Neuroscience Letters.
[81] W. Markesbery,et al. Decreased base excision repair and increased helicase activity in Alzheimer's disease brain , 2000, Brain Research.
[82] C. Masters,et al. Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. , 1999, The Journal of biological chemistry.
[83] K. McNaught,et al. Altered Glial Function Causes Neuronal Death and Increases Neuronal Susceptibility to 1‐Methyl‐4‐Phenylpyridinium‐ and 6‐Hydroxydopamine‐Induced Toxicity in Astrocytic/Ventral Mesencephalic Co‐Cultures , 1999, Journal of neurochemistry.
[84] R. Nicoll,et al. Long-term potentiation--a decade of progress? , 1999, Science.
[85] R. Barouki,et al. Repression of gene expression by oxidative stress. , 1999, The Biochemical journal.
[86] A. Graybiel,et al. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. , 1999, Brain : a journal of neurology.
[87] T. Wieloch,et al. Differences in the Activation of the Mitochondrial Permeability Transition Among Brain Regions in the Rat Correlate with Selective Vulnerability , 1999, Journal of neurochemistry.
[88] Xudong Huang,et al. The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. , 1999, Biochemistry.
[89] D. Cory-Slechta,et al. Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss , 1999, Brain Research.
[90] W. Markesbery,et al. Increased Nuclear DNA Oxidation in the Brain in Alzheimer's Disease , 1998, Journal of neurochemistry.
[91] M. Michaelis,et al. Age-related decrease in brain synaptic membrane Ca2+-ATPase in F344/BNF1 rats , 1998, Neurobiology of Aging.
[92] E. Klann,et al. Cell-permeable scavengers of superoxide prevent long-term potentiation in hippocampal area CA1. , 1998, Journal of neurophysiology.
[93] M. Berridge. Neuronal Calcium Signaling , 1998, Neuron.
[94] D. Clapham,et al. NMDA receptors amplify calcium influx into dendritic spines during associative pre- and postsynaptic activation , 1998, Nature Neuroscience.
[95] T. Montine,et al. Distribution of Reducible 4‐Hydroxynonenal Adduct Immunoreactivity in Alzheimer Disease is Associated with APOE Genotype , 1998, Journal of neuropathology and experimental neurology.
[96] J. Denu,et al. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. , 1998, Biochemistry.
[97] E. Mackenzie,et al. Selective Neuronal Vulnerability and Specific Glial Reactions in Hippocampal and Neocortical Organotypic Cultures Submitted to Ischemia , 1998, Experimental Neurology.
[98] J. Sweatt,et al. A Role for Superoxide in Protein Kinase C Activation and Induction of Long-term Potentiation* , 1998, The Journal of Biological Chemistry.
[99] E. Gahtan,et al. Reversible impairment of long‐term potentiation in transgenic Cu/Zn‐SOD mice , 1998, The European journal of neuroscience.
[100] J. Vornov,et al. Regional Vulnerability to Endogenous and Exogenous Oxidative Stress in Organotypic Hippocampal Culture , 1998, Experimental Neurology.
[101] A. Verkhratsky,et al. Calcium and neuronal ageing , 1998, Trends in Neurosciences.
[102] Y. Ishikawa,et al. Production of Reactive Oxygen Species and Release of l‐Glutamate During Superoxide Anion‐Induced Cell Death of Cerebellar Granule Neurons , 1998, Journal of neurochemistry.
[103] R. Schmidt,et al. Axonal cytoskeletal pathology in aged and diabetic human sympathetic autonomic ganglia , 1997, Brain Research.
[104] M Matsuo,et al. [Oxidative stress and aging]. , 1997, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.
[105] F. Iannotti,et al. Differential Vulnerability of the CA1 and CA3 Subfields of the Hippocampus to Superoxide and Hydroxyl Radicals In Vitro , 1997, Journal of neurochemistry.
[106] J. David Sweatt,et al. A Requirement for the Mitogen-activated Protein Kinase Cascade in Hippocampal Long Term Potentiation* , 1997, The Journal of Biological Chemistry.
[107] K. Chen,et al. Calcium Channel Density and Hippocampal Cell Death with Age in Long-Term Culture , 1997, The Journal of Neuroscience.
[108] G. Mathern,et al. Human Fascia Dentata Anatomy and Hippocampal Neuron Densities Differ Depending on the Epileptic Syndrome and Age at First Seizure , 1997, Journal of neuropathology and experimental neurology.
[109] D. German,et al. Midbrain dopaminergic neurons in the mouse that contain calbindin-D28k exhibit reduced vulnerability to MPTP-induced neurodegeneration. , 1996, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.
[110] D. German,et al. Midbrain dopaminergic neurons in the mouse: co-localization with Calbindin-D28k and calretinin , 1996, Neuroscience.
[111] M. Michaelis,et al. Decreased plasma membrane calcium transport activity in aging brain. , 1996, Life sciences.
[112] A. Martínez-Serrano,et al. Cytosolic and mitochondrial calcium in synaptosomes during aging. , 1996, Life sciences.
[113] Philip W. Landfield,et al. Increase in Single L-Type Calcium Channels in Hippocampal Neurons During Aging , 1996, Science.
[114] Lucien T. Thompson,et al. Age-related loss of calcium binding proteins in rabbit hippocampus , 1996, Neurobiology of Aging.
[115] A. Hühmer,et al. Accumulation of nitrotyrosine on the SERCA2a isoform of SR Ca‐ATPase of rat skeletal muscle during aging: a peroxynitrite‐mediated process? , 1996, FEBS letters.
[116] M. O’Banion,et al. Regional neuronal loss in aging and Alzheimer's disease: a brief review , 1994 .
[117] H. Monyer,et al. NMDA receptor channels: Subunit-specific potentiation by reducing agents , 1994, Neuron.
[118] J. Disterhoft,et al. Nimodipine decreases calcium action potentials in rabbit hippocampal CA1 neurons in an age‐dependent and concentration‐dependent manner , 1994, Hippocampus.
[119] J. Coyle,et al. Oxidative stress, glutamate, and neurodegenerative disorders. , 1993, Science.
[120] R. Schmidt,et al. Effect of diabetes and aging on human sympathetic autonomic ganglia. , 1993, The American journal of pathology.
[121] E. Masliah,et al. Quantitative synaptic alterations in the human neocortex during normal aging , 1993, Neurology.
[122] S. Fahn,et al. The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it , 1992, Annals of neurology.
[123] P. Mazzarello,et al. DNA repair mechanisms in neurological diseases: facts and hypotheses , 1992, Journal of the Neurological Sciences.
[124] G. Kreutzberg,et al. Cytotoxicity of microglia , 1992, Journal of Neuroimmunology.
[125] C. Cross,et al. Free radicals, antioxidants, and human disease: where are we now? , 1992, The Journal of laboratory and clinical medicine.
[126] B. A. Brooks,et al. Midbrain Dopaminergic Cell Loss in Parkinson's Disease and MPTP‐Induced Parkinsonism: Sparing of Calbindin‐D25k—Containing Cells a , 1992, Annals of the New York Academy of Sciences.
[127] A. Graybiel,et al. Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[128] A. Martínez-Serrano,et al. Calcium binding to the cytosol and calcium extrusion mechanisms in intact synaptosomes and their alterations with aging. , 1992, The Journal of biological chemistry.
[129] M. Michaelis,et al. Regulation of calcium levels in brain tissue from adult and aged rats , 1992, Mechanisms of Ageing and Development.
[130] M. Beal,et al. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? , 1992, Annals of neurology.
[131] J. Krieglstein,et al. Calbindin‐D28K and ischemic damage of pyramidal cells in rat hippocampus , 1992, Journal of neuroscience research.
[132] J. Sarvey,et al. Free radicals accelerate the decay of long-term potentiation in field CA1 of guinea-pig hippocampus , 1991, Neuroscience.
[133] R. Schmidt-Kastner,et al. Selective vulnerability of the hippocampus in brain ischemia , 1991, Neuroscience.
[134] D. Salmon,et al. Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.
[135] M. Mattson,et al. Evidence for calcium-reducing and excitoprotective roles for the calcium-binding protein calbindin-1328k in cultured hippocampal neurons , 1991, Neuron.
[136] P. Mcgeer,et al. Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K , 1990, Brain Research.
[137] J. E. Franck,et al. Glutamate-mediated selective vulnerability to ischemia is present in organotypic cultures of hippocampus , 1990, Neuroscience Letters.
[138] K. Takeshige,et al. 1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles. , 1990, Biochemical and biophysical research communications.
[139] J. Olney,et al. Excitotoxicity of l-DOPA and 6-OH-DOPA: Implications for Parkinson's and Huntington's diseases , 1990, Experimental Neurology.
[140] S. B. Kater,et al. Development and selective neurodegeneration in cell cultures from different hippocampal regions , 1989, Brain Research.
[141] A. Graybiel,et al. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease , 1988, Nature.
[142] D. German,et al. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonian syndrome in Macaca fascicularis: Which midbrain dopaminergic neurons are lost? , 1988, Neuroscience.
[143] C. Marsden,et al. An immunohistochemical study of the acute and long-term effects of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in the marmoset , 1987, Neuroscience.
[144] C. Colton,et al. Production of superoxide anions by a CNS macrophage, the microglia , 1987, FEBS letters.
[145] G. Gibson,et al. Calcium and the aging nervous system , 1987, Neurobiology of Aging.
[146] R. DeTeresa,et al. Neocortical cell counts in normal human adult aging , 1987, Annals of neurology.
[147] J. Vitorica,et al. Involvement of mitochondria in the age-dependent decrease in calcium uptake of rat brain synaptosomes , 1986, Brain Research.
[148] C. Gerfen,et al. The neostriatal mosaic: compartmental distribution of calcium-binding protein and parvalbumin in the basal ganglia of the rat and monkey. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[149] R. Tarone,et al. Parkinson's disease and Alzheimer's disease: hypersensitivity to X rays in cultured cell lines. , 1985, Journal of neurology, neurosurgery, and psychiatry.
[150] T. A. Pitler,et al. Prolonged Ca2+-dependent afterhyperpolarizations in hippocampal neurons of aged rats. , 1984, Science.
[151] D. Jacobowitz,et al. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[152] S. Orrenius,et al. The metabolism of menadione (2-methyl-1,4-naphthoquinone) by isolated hepatocytes. A study of the implications of oxidative stress in intact cells. , 1982, The Journal of biological chemistry.
[153] G. Cohen,et al. 6-Hydroxydopamine: Evidence for Superoxide Radical as an Oxidative Intermediate , 1973, Science.
[154] E. Streicher. Age changes in the calcium content of rat brain. , 1958, Journal of gerontology.
[155] A. Ludolph,et al. Amyotrophic lateral sclerosis. , 2012, Current opinion in neurology.
[156] P. Shaw,et al. Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis , 2009, Journal of Neurology.
[157] D. Leibfritz,et al. Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.
[158] M. Block,et al. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms , 2007, Nature Reviews Neuroscience.
[159] C. Marsden,et al. Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease , 2005, Journal of Neural Transmission.
[160] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[161] Henry Jay Forman,et al. Redox signaling , 2004, Molecular and Cellular Biochemistry.
[162] M. Beal,et al. Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species. , 2004, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[163] Alcino J. Silva,et al. Molecular and cellular cognitive studies of the role of synaptic plasticity in memory. , 2003, Journal of neurobiology.
[164] A. Sarnowska. Application of organotypic hippocampal culture for study of selective neuronal death. , 2002, Folia neuropathologica.
[165] Dean P. Jones. Redox potential of GSH/GSSG couple: assay and biological significance. , 2002, Methods in enzymology.
[166] A. Tortiglione,et al. Differential vulnerability of cortical and cerebellar neurons in primary culture to oxygen glucose deprivation followed by reoxygenation , 2001, Journal of neuroscience research.
[167] T. Rammsayer,et al. Effects of pharmacologically induced changes in NMDA-receptor activity on long-term memory in humans. , 2001, Learning & memory.
[168] J. Hirrlinger,et al. Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. , 2000, European journal of biochemistry.
[169] M. Rice,et al. Mechanisms underlying H(2)O(2)-mediated inhibition of synaptic transmission in rat hippocampal slices. , 2000, Brain research.
[170] C. DeCarli,et al. NAD(P)H:quinone oxidoreductase activity is increased in hippocampal pyramidal neurons of patients with Aalzheimer's disease. , 2000, Neurobiology of aging.
[171] A. Raina,et al. Quinone reductase (NQO1), a sensitive redox indicator, is increased in Alzheimer's disease. , 1999, Redox report : communications in free radical research.
[172] H. Hung,et al. MPTP produces differential oxidative stress and antioxidative responses in the nigrostriatal and mesolimbic dopaminergic pathways. , 1998, Free radical biology & medicine.
[173] H. Forman,et al. Oxidants as stimulators of signal transduction. , 1997, Free radical biology & medicine.
[174] M. Portolés,et al. Loss of granule neurons in the aging human cerebellar cortex. , 1996, The International journal of developmental biology.
[175] M. Bear,et al. Long-term depression in hippocampus. , 1996, Annual review of neuroscience.
[176] M. Graeber,et al. Surveillance, intervention and cytotoxicity: is there a protective role of microglia? , 1994, Developmental neuroscience.
[177] C. Marsden,et al. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental lewy body disease , 1992, Annals of neurology.
[178] J. Stamler,et al. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[179] L. Fagni,et al. The action of hydrogen peroxide on paired pulse and long-term potentiation in the hippocampus. , 1989, Free radical biology & medicine.
[180] A. Nappi,et al. Alzheimer ' s Disease : Cell-Specific Pathology Isolates the Hippocampal Formation , 2022 .